{"id":"https://openalex.org/W7098656198","doi":null,"title":"Moavero R: mTOR inhibitors in tuberous sclerosis complex. Curr Neuropharmacol 10","display_name":"Moavero R: mTOR inhibitors in tuberous sclerosis complex. Curr Neuropharmacol 10","alternate_titles":[],"publication_year":null,"publication_date":null,"ids":{"openalex":"https://openalex.org/W7098656198"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.776.148","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.776.148","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/7e/d2/CN-10-404.PMC3520048.pdf","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7098656198"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Paolo Curatolo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paolo Curatolo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5081255561","display_name":"Romina Moavero","orcid":"https://orcid.org/0000-0002-6200-060X","observed_orcids":["https://orcid.org/0000-0002-6200-060X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Romina Moavero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T12049","display_name":"Tuberous Sclerosis Complex Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12049","display_name":"Tuberous Sclerosis Complex Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12355","display_name":"Genetic and rare skin diseases.","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tuberous-sclerosis-complex","display_name":"tuberous sclerosis complex","score":1.0},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.9380000233650208},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":1.0},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.7990000247955322},{"id":"https://openalex.org/keywords/tsc1-and-tsc2-mutations","display_name":"TSC1 and TSC2 mutations","score":0.8709999918937683},{"id":"https://openalex.org/keywords/subependymal-giant-cell-astrocytoma","display_name":"subependymal giant cell astrocytoma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/renal-angiomyolipoma","display_name":"renal angiomyolipoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8320000171661377},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9020000100135803},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C2776773979","wikidata":"https://www.wikidata.org/wiki/Q898669","display_name":"TSC1","level":4,"score":0.9125999808311462},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.8880000114440918},{"id":"https://openalex.org/C2778980267","wikidata":"https://www.wikidata.org/wiki/Q1362721","display_name":"Tuberous sclerosis","level":2,"score":0.8741000294685364},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.828000009059906},{"id":"https://openalex.org/C2779422105","wikidata":"https://www.wikidata.org/wiki/Q21109261","display_name":"TSC2","level":4,"score":0.8154000043869019},{"id":"https://openalex.org/C2777921159","wikidata":"https://www.wikidata.org/wiki/Q32089","display_name":"Sirolimus","level":2,"score":0.7414000034332275},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6855999827384949},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5554999709129333},{"id":"https://openalex.org/C2776340667","wikidata":"https://www.wikidata.org/wiki/Q122222","display_name":"Subependymal giant cell astrocytoma","level":4,"score":0.482699990272522},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4722000062465668},{"id":"https://openalex.org/C43060935","wikidata":"https://www.wikidata.org/wiki/Q18043110","display_name":"RPTOR","level":4,"score":0.4706999957561493},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.4596000015735626},{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.37209999561309814},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.37040001153945923},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3465000092983246},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3296000063419342},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.3255999982357025},{"id":"https://openalex.org/C2779997425","wikidata":"https://www.wikidata.org/wiki/Q1878759","display_name":"Lymphangioleiomyomatosis","level":3,"score":0.3183000087738037},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.301800012588501},{"id":"https://openalex.org/C2777949483","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"Mechanistic target of rapamycin","level":4,"score":0.29499998688697815},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.27320000529289246},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2727000117301941},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.2696000039577484},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.2621999979019165},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.2596000134944916},{"id":"https://openalex.org/C203522944","wikidata":"https://www.wikidata.org/wiki/Q288322","display_name":"Autophagy","level":3,"score":0.2565999925136566},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.25440001487731934}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.776.148","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.776.148","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/7e/d2/CN-10-404.PMC3520048.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4232786548","https://openalex.org/W2116542833","https://openalex.org/W2291704585","https://openalex.org/W2133088987","https://openalex.org/W2593388662","https://openalex.org/W1834745188","https://openalex.org/W2259261531","https://openalex.org/W4388569221","https://openalex.org/W2125460508","https://openalex.org/W2145273805"],"abstract_inverted_index":{"Abstract:":[0],"Tuberous":[1],"sclerosis":[2],"complex":[3],"(TSC)":[4],"is":[5,13,83],"a":[6,62,90,121],"genetic":[7],"multiple":[8],"organ":[9],"system":[10],"disorder":[11],"that":[12,158],"characterized":[14],"by":[15],"the":[16,27,36,46,72,84,94,115,147,171,174,181],"development":[17],"of":[18,38,45,49,117,123,149,173,188],"tumor-like":[19],"lesions":[20],"(hamartomas)":[21],"and":[22,29,54,69,96,133,146,179,186],"neurodevelopmental":[23],"disorders.":[24],"Mutations":[25],"in":[26,35,43,57,93,97,120,142,164,177,196],"TSC1":[28],"TSC2":[30],"tumor":[31],"suppressor":[32],"genes":[33],"occur":[34],"majority":[37],"patients":[39,79,100],"with":[40,80,101,107,192],"TSC,":[41],"resulting":[42],"hyperactivation":[44],"mammalian":[47],"target":[48],"rapamycin":[50],"(mTOR)":[51],"signaling":[52],"pathway":[53,176],"subsequent":[55],"abnormalities":[56],"numerous":[58],"cell":[59],"processes.":[60],"As":[61],"result,":[63],"mTOR":[64,86,118,140,175,189],"inhibitors":[65,119,141],"such":[66],"as":[67,89],"sirolimus":[68],"everolimus":[70],"have":[71],"potential":[73],"to":[74,112,154],"provide":[75,155],"targeted":[76],"therapy":[77],"for":[78,99],"TSC.":[81,108],"Everolimus":[82],"first":[85],"inhibitor":[87],"approved":[88],"treatment":[91],"option":[92],"USA":[95],"Europe":[98],"subependymal":[102],"giant-cell":[103],"astrocytomas":[104],"(SEGAs)":[105],"associated":[106],"The":[109],"clinical":[110,137,184,197],"evidence":[111,157],"date":[113],"supports":[114],"use":[116],"variety":[122],"TSC-associated":[124],"disease":[125],"manifestations,":[126,132],"including":[127],"SEGAs,":[128],"renal":[129],"angiomyolipoma,":[130],"skin":[131],"epilepsy.":[134],"Furthermore,":[135],"ongoing":[136],"trials":[138],"evaluating":[139],"TSC":[143,178],"are":[144,152],"underway,":[145],"results":[148],"these":[150],"studies":[151],"expected":[153],"further":[156],"will":[159,169],"firmly":[160],"establish":[161],"their":[162,193],"role":[163,172],"this":[165],"setting.":[166],"This":[167],"article":[168],"discuss":[170],"review":[180],"pharmacokinetics,":[182],"pharmacodynamics,":[183],"efficacy,":[185],"tolerability":[187],"inhibitors,":[190],"along":[191],"current":[194],"place":[195],"practice.":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7098656198","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-10-27T00:00:00"}
